Market Insights Consumer OTC Pharmaceuticals

Wound Care - United Arab Emirates

United Arab Emirates

Revenue in the Wound Care market amounts to €3.89m in 2024. The market is expected to grow annually by 0.51% (CAGR 2024-2029).
In global comparison, most revenue is generated in the United States (€975m in 2024).
In relation to total population figures, per person revenues of €0.41 are generated in 2024.

Key regions: United States, Indonesia, Germany, Europe, United Kingdom

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Wound Care market in United Arab Emirates is experiencing significant development due to several factors.

Customer preferences: In recent years, there has been a growing demand for advanced wound care products in the United Arab Emirates. This can be attributed to the increasing awareness among consumers about the importance of wound care and the availability of innovative products in the market. Customers in the UAE are increasingly seeking products that offer faster healing, minimize scarring, and provide better overall wound management. As a result, there is a shift towards the use of products such as advanced dressings, wound closure devices, and negative pressure wound therapy systems.

Trends in the market: One of the key trends in the Wound Care market in the United Arab Emirates is the adoption of advanced wound care products. These products, which include advanced dressings and wound closure devices, offer several advantages over traditional wound care products. They provide better moisture management, promote faster healing, and reduce the risk of infection. The increasing prevalence of chronic wounds, such as diabetic foot ulcers and pressure ulcers, has also contributed to the demand for advanced wound care products. Another trend in the market is the growing popularity of telemedicine and telehealth services for wound care management. These services allow healthcare professionals to remotely monitor and manage wounds, reducing the need for frequent hospital visits. This trend has gained traction in the United Arab Emirates due to the convenience it offers to patients, especially those living in remote areas or with limited access to healthcare facilities.

Local special circumstances: The United Arab Emirates has a high prevalence of chronic diseases, such as diabetes and obesity, which are major risk factors for chronic wounds. This has led to an increased demand for wound care products and services in the country. Additionally, the UAE has a large expatriate population, which contributes to the demand for wound care products and services.

Underlying macroeconomic factors: The United Arab Emirates has a strong healthcare infrastructure and is investing heavily in the development of its healthcare sector. This includes the expansion of healthcare facilities, the recruitment of skilled healthcare professionals, and the implementation of advanced technologies. These initiatives have created a favorable environment for the growth of the Wound Care market in the country. Furthermore, the United Arab Emirates has a high disposable income per capita, which enables individuals to afford advanced wound care products and services. The government also provides healthcare subsidies and insurance coverage, making healthcare more accessible to the population. In conclusion, the Wound Care market in the United Arab Emirates is developing due to the increasing demand for advanced wound care products, the adoption of telemedicine and telehealth services, the high prevalence of chronic diseases, and the country's strong healthcare infrastructure and favorable economic conditions.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.